Testing for responses to the wrong SARS-CoV-2 antigen?
作者信息
Rosadas Carolina, Randell Paul, Khan Maryam, McClure Myra O, Tedder Richard S
机构信息
Department of Infectious Disease, Imperial College London, London, UK.
Department of Infection and Immunity, Imperial College Healthcare NHS Trust, Charing Cross Hospital, London, UK.
出版信息
Lancet. 2020 Sep 5;396(10252):e23. doi: 10.1016/S0140-6736(20)31830-4. Epub 2020 Aug 28.
Abstract
摘要
相似文献
1
Testing for responses to the wrong SARS-CoV-2 antigen?
Lancet. 2020 Sep 5;396(10252):e23. doi: 10.1016/S0140-6736(20)31830-4. Epub 2020 Aug 28.
2
Evaluations of the serological test in the diagnosis of 2019 novel coronavirus (SARS-CoV-2) infections during the COVID-19 outbreak.
Eur J Clin Microbiol Infect Dis. 2020 Dec;39(12):2271-2277. doi: 10.1007/s10096-020-03978-6. Epub 2020 Jul 17.
3
Evaluation of seven commercial SARS-CoV-2 RNA detection kits based on real-time polymerase chain reaction (PCR) in China.
Clin Chem Lab Med. 2020 Jul 13;58(9):e149-e153. doi: 10.1515/cclm-2020-0271. Print 2020 Aug 27.
4
A reverse-transcription recombinase-aided amplification assay for the rapid detection of N gene of severe acute respiratory syndrome coronavirus 2(SARS-CoV-2).
Virology. 2020 Oct;549:1-4. doi: 10.1016/j.virol.2020.07.006. Epub 2020 Jul 29.
5
Accurate serology for SARS-CoV-2 and common human coronaviruses using a multiplex approach.
Emerg Microbes Infect. 2020 Dec;9(1):1965-1973. doi: 10.1080/22221751.2020.1813636.
6
Serology assays to manage COVID-19.
Science. 2020 Jun 5;368(6495):1060-1061. doi: 10.1126/science.abc1227. Epub 2020 May 15.
7
Response of anti-SARS-CoV-2 total antibodies to nucleocapsid antigen in COVID-19 patients: a longitudinal study.
Clin Chem Lab Med. 2020 Sep 25;58(10):e193-e196. doi: 10.1515/cclm-2020-0962.
8
Orthogonal SARS-CoV-2 Serological Assays Enable Surveillance of Low-Prevalence Communities and Reveal Durable Humoral Immunity.
Immunity. 2020 Nov 17;53(5):925-933.e4. doi: 10.1016/j.immuni.2020.10.004. Epub 2020 Oct 14.
9
Sensitivity in Detection of Antibodies to Nucleocapsid and Spike Proteins of Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Coronavirus Disease 2019.
J Infect Dis. 2020 Jun 29;222(2):206-213. doi: 10.1093/infdis/jiaa273.
10
Two serological approaches for detection of antibodies to SARS-CoV-2 in different scenarios: a screening tool and a point-of-care test.
Diagn Microbiol Infect Dis. 2020 Dec;98(4):115167. doi: 10.1016/j.diagmicrobio.2020.115167. Epub 2020 Aug 11.
引用本文的文献
1
Fusing Peptide Epitopes for Advanced Multiplex Serological Testing for SARS-CoV-2 Antibody Detection.
ACS Bio Med Chem Au. 2023 Aug 30;4(1):37-52. doi: 10.1021/acsbiomedchemau.3c00010. eCollection 2024 Feb 21.
2
Evaluation of qualitative and semi-quantitative cut offs for rapid diagnostic lateral flow test in relation to serology for the detection of SARS-CoV-2 antibodies: findings of a prospective study.
BMC Infect Dis. 2022 Oct 31;22(1):810. doi: 10.1186/s12879-022-07786-5.
3
Waning of SARS-CoV-2 Seropositivity among Healthy Young Adults over Seven Months.
Vaccines (Basel). 2022 Sep 15;10(9):1532. doi: 10.3390/vaccines10091532.
4
Tracking the incidence and risk factors for SARS-CoV-2 infection using historical maternal booking serum samples.
PLoS One. 2022 Sep 2;17(9):e0273966. doi: 10.1371/journal.pone.0273966. eCollection 2022.
5
The influence of time on the sensitivity of SARS-CoV-2 serological testing.
Sci Rep. 2022 Jun 22;12(1):10517. doi: 10.1038/s41598-022-14351-2.
6
Ethnoracial Disparities in SARS-CoV-2 Seroprevalence in a Large Cohort of Individuals in Central North Carolina from April to December 2020.
mSphere. 2022 Jun 29;7(3):e0084121. doi: 10.1128/msphere.00841-21. Epub 2022 May 19.
7
Post-COVID-19 syndrome and humoral response association after 1 year in vaccinated and unvaccinated patients.
Clin Microbiol Infect. 2022 Aug;28(8):1140-1148. doi: 10.1016/j.cmi.2022.03.016. Epub 2022 Mar 23.
8
The Influence of Time on the Sensitivity of SARS-CoV-2 Serological Testing.
Res Sq. 2022 Feb 17:rs.3.rs-1286644. doi: 10.21203/rs.3.rs-1286644/v1.
9
Simple, sensitive, specific self-sampling assay secures SARS-CoV-2 antibody signals in sero-prevalence and post-vaccine studies.
Sci Rep. 2022 Feb 3;12(1):1885. doi: 10.1038/s41598-022-05640-x.
10
Variability in detection of SARS-CoV-2-specific antibody responses following mild infection: a prospective multicentre cross-sectional study, London, United Kingdom, 17 April to 17 July 2020.
Euro Surveill. 2022 Jan;27(4). doi: 10.2807/1560-7917.ES.2022.27.4.2002076.
本文引用的文献
1
Differences in Antibody Kinetics and Functionality Between Severe and Mild Severe Acute Respiratory Syndrome Coronavirus 2 Infections.
J Infect Dis. 2020 Sep 14;222(8):1265-1269. doi: 10.1093/infdis/jiaa463.
2
Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections.
Nat Med. 2020 Aug;26(8):1200-1204. doi: 10.1038/s41591-020-0965-6. Epub 2020 Jun 18.
3
Whole Nucleocapsid Protein of Severe Acute Respiratory Syndrome Coronavirus 2 May Cause False-Positive Results in Serological Assays.
Clin Infect Dis. 2021 Apr 8;72(7):1291-1292. doi: 10.1093/cid/ciaa637.
Zotero 插件